L502-1326 Screening compound: 4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)thiophene-2-sulfonamide

L502-1326 Screening compound: 4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)thiophene-2-sulfonamide
L502-1326 Screening compound: 4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)thiophene-2-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L502-1326
4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)thiophene-2-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L502-1326

Molecular Formula

C19H24N4O6S2 (C19 H24 N4 O6 S2)

Compound Name

4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-N-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)thiophene-2-sulfonamide

IUPAC name

4-(5-cyclobutyl-124-oxadiazol-3-yl)-N-(2-{14-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)thiophene-2-sulfonamide

SMILES

O=C(CNS(c1cc(-c2noc(C3CCC3)n2)cs1)(=O)=O)N(CC1)CCC11OCCO1

InChI

InChI=1S/C19H24N4O6S2/c24-15(23-6-4-19(5-7-23)27-8-9-28-19)11-20-31(25,26)16-10-14(12-30-16)17-21-18(29-22-17)13-2-1-3-13/h10,12-13,20H,1-9,11H2

InChI Key

KVIOIHYVNNGZMN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15128905

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.55

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.617

Distribution Coefficient, logD

1.606

Water Solubility, LogSw

-2.43

Polar Surface Area

105.773

Acid Dissociation Constant (pKa)

8.97

Base Dissociation Constant (pKb)

-0.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

63.20

L502-1326 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L502-1326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L502-1326?
Check Price and Availability of L502-1326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L502-1326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L502-1326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L502-1326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L502-1326 available by request